Overview
Toshimasa Matsumoto practices practicing medicine in Hori, Japan.
Their clinical expertise encompasses Parathyroid Cancer, Parathyroid Adenoma, and Mitral Valve Regurgitation.
They are actively involved in clinical research, co-authoring 15 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Toshimasa Matsumoto
Is Toshimasa Matsumoto a top-rated expert for Parathyroid Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Toshimasa Matsumoto is classified as an Experienced expert for Parathyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Toshimasa Matsumoto participate in research or clinical trials?
Yes. Toshimasa Matsumoto has published 15 articles and abstracts on conditions like Parathyroid Cancer. You can view a list of Toshimasa Matsumoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Mitral Valve RegurgitationMatsumoto isExperienced. Learn about Mitral Valve Regurgitation.
- Parathyroid AdenomaMatsumoto isExperienced. Learn about Parathyroid Adenoma.
- Parathyroid CancerMatsumoto isExperienced. Learn about Parathyroid Cancer.